CardioMech confirmed the completion of the first procedure with its transcatheter mitral valve repair (TMVR) technology. At the Sanger Heart & Vascular Institute in North Carolina, a multidisciplinary heart team evaluated a patient diagnosed with severe symptomatic degenerative mitral regurgitation (DMR). They offered the patient a choice: … [Read more...] about CardioMech reports first in-person procedure with its transcatheter mitral valve repair tech
Catheters
Caldera launches new Desara TVez for stress urinary incontinence
Surgical product developer Caldera Medical announced today that it launched the Desara TVez as part of its Desara portfolio. Los Angeles-based Caldera’s Desara family of products includes offerings for treating stress urinary incontinence, pelvic organ prolapse and polyps. Get the full story on our sister site, MassDevice. … [Read more...] about Caldera launches new Desara TVez for stress urinary incontinence
Integer completes $220M Oscor acquisition
Integer Holdings (NYSE: ITGR) announced today that it has completed its purchase of Oscor — a deal that expands the capabilities of what was already one of the world's largest medtech contract manufacturers. Integer said the acquisition would cost $220 million when it first announced its plans in October. Oscor is the creator and marketer of … [Read more...] about Integer completes $220M Oscor acquisition
BD acquires Venclose and its RF ablation technology
BD (NYSE:BDX) announced today that it acquired Venclose and its solutions for treating chronic venous insufficiency (CVI). CVI occurs as the result of malfunctioning valves and can lead to varicose veins. Venclose’s CVI treatment uses radio frequency (RF) ablation technology, with its catheters potentially reducing post-operative pain and … [Read more...] about BD acquires Venclose and its RF ablation technology
Teleflex recalls some Arrow-Trerotola over-the-wire PTD kits
Teleflex (NYSE:TFX) announced that it initiated a worldwide recall of its Arrow-Trerotola over-the-wire PTD (percutaneous thrombolytic device) kit. Wayne, Pennsylvania-based Teleflex designed the Arrow-Trerotola (PTD) catheter in conjunction with the Arrow rotator drive unit to allow for the mechanical declotting of the native arterio-venous … [Read more...] about Teleflex recalls some Arrow-Trerotola over-the-wire PTD kits
ICU Medical’s Smiths Medical acquisition remains on track
ICU Medical (NASDAQ:ICUI) is a step closer to acquiring Smiths Medical after clearing a shareholders vote at Smiths' British parent company, the Smiths Group. Almost all of the nearly 327 million Smiths Group shareholders voting on November 17 approved the $2.35 billion buy. Run out of the Minneapolis area, Smiths Medical’s business brings in … [Read more...] about ICU Medical’s Smiths Medical acquisition remains on track
FDA clears Avinger’s Pantheris for in-stent restenosis
Avinger this week announced that it received FDA 510(k) clearance for a new clinical indication for its Pantheris image-guided atherectomy system. The new indication allows the Redwood City, California–based company to market the device for in-stent restenosis (ISR) treatment in the lower extremity arteries. “We are excited to receive FDA … [Read more...] about FDA clears Avinger’s Pantheris for in-stent restenosis
ALung Technologies wins FDA de novo nod for Hemolung respiratory assist system
ALung Technologies announced today that it received FDA de novo clearance for its Hemolung respiratory support platform. Pittsburgh-based ALung designed its Hemolung system to provide low-flow extracorporeal carbon dioxide removal (ECCO2R) for patients with acute respiratory failure. Get the full story at our sister site, MassDevice. … [Read more...] about ALung Technologies wins FDA de novo nod for Hemolung respiratory assist system
What is renal denervation? Medtronic Coronary and RDN President Jason Weidman explains
Medtronic (NYSE:MDT) continues clinical trials of its Symplicity Spyral renal denervation (RDN) system for treating hypertension. The hope now is to win FDA approval in 2023. To better understand the technology behind what Medtronic leaders expect to become a multibillion-dollar business, Medical Design & Outsourcing spoke with Jason … [Read more...] about What is renal denervation? Medtronic Coronary and RDN President Jason Weidman explains
Medtronic reports promising early data for transfemoral delivery of its Intrepid TMVR
Medtronic (NYSE:MDT) this week touted data for its Intrepid self-expanding transcatheter mitral valve replacement (TMVR) system. Early data from 15 patients in an early feasibility study was presented as late-breaking clinical science at the 33rd Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of the … [Read more...] about Medtronic reports promising early data for transfemoral delivery of its Intrepid TMVR
